Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00923598).
- Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01898689).
- Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00428116).
- Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS): Complete Statistical AnalysisIndependent statistical analysis of Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Optimizing Residential Treatment Gains for Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Residential Treatment Gains for Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05764369).
- Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03595280).
- Optimizing Self-management COPD Treatment Through the American Lung Association Helpline: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Self-management COPD Treatment Through the American Lung Association Helpline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05106257).
- Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Optimizing the Ocular Surface Prior to Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Optimizing the Ocular Surface Prior to Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02766907).
- Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OPTIMUMIndependent statistical analysis of Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02425644).
- OPTIMUS-7Independent statistical analysis of Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04484259).
- OpTIONIndependent statistical analysis of Optimal Treatment for Recurrent Clostridium Difficile: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667418).
- OPTIONIndependent statistical analysis of A Study of Oral Contraception Under Simulated OTC Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03559010).
- OPTIRPE65Independent statistical analysis of Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- OPTISCREEN-BIndependent statistical analysis of Application of HBV Rapid Tests as a Tool for Wide-Use Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OptiVol® Care Pathway: Complete Statistical AnalysisIndependent statistical analysis of OptiVol® Care Pathway: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00847288).
- OPTMIZE-OSIndependent statistical analysis of Risk Factor Control Before Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01837069).
- Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344): Complete Statistical AnalysisIndependent statistical analysis of Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01925573).
- OPUSIndependent statistical analysis of the OPUS trial of cetuximab plus FOLFOX-4 versus FOLFOX-4 alone as first-line treatment for metastatic colorectal cancer, including response, progression-free survival, overall survival, KRAS subgroup analyses, methodology, and…
- OR-VRIndependent statistical analysis of Virtual Reality in the Operating Room: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03614325).
- ORACALIndependent statistical analysis of A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oral Calcitriol With Ketoconazole in CRPC: Complete Statistical AnalysisIndependent statistical analysis of Oral Calcitriol With Ketoconazole in CRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03261336).
- Oral Contraceptives in the Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Oral Contraceptives in the Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00205504).
- Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oral Cyclosporine in Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of Oral Cyclosporine in Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00974142).
- Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): Complete Statistical AnalysisIndependent statistical analysis of Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): primary endpoint results, effect estimate with…
- Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01113385).
- Oral Health Educational Methods in Adolescence: Complete Statistical AnalysisIndependent statistical analysis of Oral Health Educational Methods in Adolescence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03216746).
- Oral Health Literacy and Oral Education: Complete Statistical AnalysisIndependent statistical analysis of Oral Health Literacy and Oral Education: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02436811).
- Oral Health Literacy Tailored Communication: Complete Statistical AnalysisIndependent statistical analysis of Oral Health Literacy Tailored Communication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01118143).
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD): Complete Statistical AnalysisIndependent statistical analysis of Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03028350).
- Oral Immunotherapy for Peanut and Mammalian Meat Allergies: Complete Statistical AnalysisIndependent statistical analysis of Oral Immunotherapy for Peanut and Mammalian Meat Allergies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02350660).
- Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): Complete Statistical AnalysisIndependent statistical analysis of Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oral Ketorolac for Arthroscopic Rotator Cuff Repair: Complete Statistical AnalysisIndependent statistical analysis of Oral Ketorolac for Arthroscopic Rotator Cuff Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03967847).
- Oral LAT8881 in Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of Oral LAT8881 in Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03865953).
- Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): Complete Statistical AnalysisIndependent statistical analysis of Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04409041).
- Oral Nifedipine Versus Oral Labetalol: Complete Statistical AnalysisIndependent statistical analysis of Oral Nifedipine Versus Oral Labetalol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02168309).
- Oral OKT3 for the Treatment of Active Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Oral OKT3 for the Treatment of Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01287195).
- Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis: Complete Statistical AnalysisIndependent statistical analysis of Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03425396).
- Oral ONC201 in Adult Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Oral ONC201 in Adult Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02525692).
- Oral ONC201 in Relapsed/Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Oral ONC201 in Relapsed/Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02863991).
- Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: Complete Statistical AnalysisIndependent statistical analysis of Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Oral Paricalcitol in Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Oral Paricalcitol in Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00587158).
- Oral Pathology Asynchronous Telementoring Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Oral Pathology Asynchronous Telementoring Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04166214).
- Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001596).
- Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495374).